Gå direkt till innehåll

Ämnen: Ekonomi, finans

  • Sanofi-aventis concludes €10 billion in medium-term credit agreements with its banks to refinance the aventis acquisition financing entered into in April 2004

    Sanofi-aventis announced today the simultaneous signature of a medium-term syndicated credit agreement amounting to €8 billion and four bilateral credit facilities amounting to €500 million each. The syndicated credit agreement consists of two revolving credit lines each having a different maturity: • a €5.5 billion five-year tranche with the possibility of extending the maturity up to seven

  • 2004 pro forma combined net sales up 10.0% on a comparable basis

    Sanofi-aventis gains market share from year one After consultation with the stock market authorities in France and the United States, sanofi-aventis has retained August 20 as the date of first consolidation. In 2004, sanofi-aventis generated consolidated net sales of 15,043 million euros compared with 8,048 million euros in 2003. In the fourth quarter of 2004, sanofi-aventis consolidated net

  • Sanofi-aventis to reorganise short-term financing

    Sanofi-aventis announced today its plan to reimburse the short-term tranche of the syndicated credit line which was put in place in April 2004 to finance the acquisition of Aventis (Tranche A). This 5 billion-Euro tranche is maturing on January 24, 2005. The company had an option to extend maturity for a maximum of one year. However, in order to optimise its financing costs, sanofi-aventis has